Senior insider sale
Chief Financial Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$7.2K
3.02K shares
What this filing means
DELFINI LISA plans to sell 3.02K shares of TREVI THERAPEUTICS, INC. valued at approximately $7.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2023ACC: 0001972481-23-000023
Officer· Chief Financial Officer
Since Aug 2021
3.02K
Shares to sell
$7.2K
Approx. market value
2.08K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Options Exercise
Sell to cover
6/12/2023
2.08KTotal acquired2.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2023 | Options Exercise Sell to cover | 2.08K | — |
| Total | 2.08K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
562.00
Market value
$1.6K
5/11/2023
—Completed
Units to sell
840.00
Market value
$1.5K
4/11/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.61K
Market value
$4.2K
6/12/2023
Total
Units
3.02K
Value
$7.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/11/2023 | 562.00 | $1.6K | — | Completed |
4/11/2023 | 840.00 | $1.5K | — | Completed |
| Planned — Approximate Date | ||||
6/12/2023 | 1.61K | $4.2K | NASDAQ | Planned |
| Total | 3.02K | $7.2K | ||